Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Classical hematology 1

Conditions

Breast Neoplasms 3Lung Neoplasms 2Hot Flashes 2Carcinoma, Non-Small-Cell Lung 2Urinary Bladder Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Recurrence 1Peripheral Nervous System Diseases 1Febrile Neutropenia 1Cross Infection 1

Interventions

anlotinib 3Injections 3Doxorubicin 3toripalimab 1spartalizumab 1penpulimab 1pemigatinib 1pazopanib 1montelukast 1liposomal doxorubicin 1eribulin 1chlorhexidine gluconate 1camrelizumab 1bexmarilimab 1apatinib 1X-Rays 1Trabectedin 1Temozolomide 1Tablets 1Surgical Procedures, Operative 1Sodium Chloride 1Radiotherapy 1Proton Therapy 1Positron Emission Tomography Computed Tomography 1Nivolumab 1Neoadjuvant Therapy 1Negative-Pressure Wound Therapy 1KP 1339 1Ipilimumab 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Sarcoma × Acupuncture Therapy × Clear all
NCT06500715 2026-04-29

Acupuncture as add-on to G-CSF for Febrile Neutropenia-related Hospitalization in Doxorubicin-treated Patients With Sarcoma

Shaare Zedek Medical Center

Phase NA Not yet recruiting
60 enrolled
Classical hematologySarcoma

Cross Infection, Sarcoma, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡